NCI-sponsored Clinical Trial Research Specialist
NCI 资助的临床试验研究专家
基本信息
- 批准号:10720142
- 负责人:
- 金额:$ 11.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAwardCancer CenterClinical InvestigatorClinical ResearchClinical TrialsClinical Trials NetworkColonColorectal CancerCommittee MembersCommunicationCommunity Clinical Oncology ProgramConduct Clinical TrialsDevelopmentDiseaseEnrollmentFloridaFutureGoalsHealthHepatobiliaryInstitutionInvestigational TherapiesLeadershipMalignant neoplasm of anusMentorshipNational Clinical Trials NetworkNeurosecretory SystemsOncologyPancreasPatient ParticipationPatientsPediatric Oncology GroupPeer ReviewPositioning AttributeProcessProductivityRectumResearchResearch PersonnelScientistServicesSpecialistVotingWagescareercostdata centersexpectationexperiencefaculty supportgastrointestinalimprovedmeetingsmembernext generationoncology programoncology trialprogramsrectalstatistical centersuccess
项目摘要
ABSTRACT
NCI-sponsored clinical trials represent some of the highest priority clinical trials conducted by the UF Health
Cancer Center (UFHCC). These trials include participation by patients seen at our center as well as those
through our academic research consortium across the entire state of Florida to deliver trial access to where
patients are. The UFHCC is committed to the success of NCI-sponsored clinical trials through robust partnerships
with the National Clinical Trials Network (NCTN) through the Children's Oncology Group (COG), NRG Oncology
as well as the Experimental Therapeutics Clinical Trial Network (ETCTN). This commitment is demonstrated at
multiple levels including, but not limited to, prioritizing investigator participation in NCI-sponsored clinical trials,
facilitating rapid and efficient activation, financially subsidizing the costs of trial conduct, supporting faculty to
attend meetings serving as content experts/committee members, hosting the COG Statistical and Data Center,
embedding expectations for participation into salary support, and providing a mechanism to allow regional
community oncology practices to access trials. My involvement and effort at each of these institutional levels has
resulted in improved productivity, efficiency, and impact. These include my leadership as the inaugural UFHCC
Associate Director for Clinical Research (ADCR), Director of the Experimental Therapeutics Group, and Director
of the GI Oncology Program. Portfolio priority, oversight and enrollments to the NCI-sponsored clinical trials are
a demonstrated institutional priority. Within the NCI-sponsored clinical trial networks, I am also active and provide
impact through administrative leadership. I serve as the NRG Oncology Co-Chair of the GI Committee, Chair of
the Colorectal Cancer Subcommittee, and member of the Communications Committee. I also serve as the
UFHCC institutional PI to the ETCTN and Yale LAO member. I am personally involved in the NCI peer-review
process by which concepts are evaluated for scientific merit, impact, and feasibility prior to being approved as
trials. These reviews occur in the NCI disease-specific Task Forces, specifically, the Esophagogastric,
Hepatobiliary, Pancreatic, Neuroendocrine, Colon, and Rectal-Anal Cancer NCI Task Forces as well as trial final
approval as a voting member of the NCI Gastrointestinal Steering Committee. Through these positions and with
additional contributions, I have actively and positively influenced the current and future landscape of the NCTN
and ETCTN programs, particularly the GI Oncology trial portfolio. My career goals include continued service to
the NCI-sponsored clinical trial networks through leadership, new member engagement and trial
development/completion while simultaneously increasing my institutional engagement through expanded trial
conduct and expanding the next generation of capable and diverse NCI clinical investigators leveraging my
leadership, experience, mentorship, and sponsorship.
摘要
国家癌症研究所主办的临床试验代表了一些最高优先级的临床试验进行的UF健康
癌症中心(UFHCC)。这些试验包括在我们中心就诊的患者以及
通过我们在整个佛罗里达州的学术研究联盟,
病人是。UFHCC致力于通过强大的合作伙伴关系使NCI申办的临床试验取得成功
与国家临床试验网络(NCTN)通过儿童肿瘤组(COG),NRG肿瘤
实验治疗学临床试验网络(ETCTN)这一承诺体现在
多个层面,包括但不限于优先考虑研究者参与NCI申办的临床试验,
促进快速和有效的激活,财政补贴的费用进行试验,支持教师,
作为内容专家/委员会成员参加会议,主持COG统计和数据中心,
将对参与的期望纳入工资支持,并提供一种机制,
社区肿瘤学实践来访问试验。我在这些机构层面的参与和努力,
提高了生产力、效率和影响力。其中包括我作为首届UFHCC的领导
临床研究副总监(ADCR),实验治疗组总监,
胃肠肿瘤学项目的负责人组合优先级、监督和入组NCI申办的临床试验是
一个明显的机构优先事项。在NCI赞助的临床试验网络中,我也很活跃,并提供
通过行政领导的影响。我担任GI委员会的NRG肿瘤学联合主席,
结肠直肠癌小组委员会和通信委员会成员。我也是
ETCTN和耶鲁LAO成员的UFHCC机构PI。我亲自参与了国家癌症研究所的同行评审
概念在被批准之前对科学价值、影响和可行性进行评估的过程,
审判这些评论发生在NCI疾病特异性工作组,特别是食管胃,
肝胆癌、胰腺癌、神经内分泌癌、结肠癌和直肠肛门癌NCI工作组以及试验终末
批准作为NCI胃肠指导委员会的投票成员。通过这些立场,并与
除了额外的贡献,我还积极地影响了NCTN当前和未来的前景
和ETCTN计划,特别是GI肿瘤试验组合。我的职业目标包括继续为
通过领导、新成员参与和试验,建立NCI赞助的临床试验网络
开发/完成,同时通过扩大试验增加我的机构参与
引导和扩大下一代有能力和多样化的NCI临床研究者,利用我的
领导力、经验、指导和赞助。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas J. George其他文献
Support for people with long-term neurological conditions in rural English communities.
为英国农村社区患有长期神经系统疾病的人们提供支持。
- DOI:
10.12968/bjcn.2019.24.5.212 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Michael Toze;Kelly Sisson;Thomas J. George;Mo Ray - 通讯作者:
Mo Ray
Influential factors on treatment decision making among patients with colorectal cancer: A scoping review
- DOI:
10.1007/s00520-017-3763-z - 发表时间:
2017-06-06 - 期刊:
- 影响因子:3.000
- 作者:
Nicole M. Cranley;Barbara Curbow;Thomas J. George;Juliette Christie - 通讯作者:
Juliette Christie
Validation of a pelvic surgery difficulty risk model to predict difficult pelvic dissection and poor outcomes
- DOI:
10.1016/j.surg.2022.12.023 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:
- 作者:
Atif Iqbal;Aimal Khan;Steven Hughes;Thomas J. George;Sanda Tan;Hector Garcia-Chavez;Thomas Read - 通讯作者:
Thomas Read
5-FU induced cardiotoxicity: case series and review of the literature
- DOI:
10.1186/s40959-019-0048-3 - 发表时间:
2019-09-06 - 期刊:
- 影响因子:3.200
- 作者:
Cai Yuan;Hiral Parekh;Carmen Allegra;Thomas J. George;Jason S. Starr - 通讯作者:
Jason S. Starr
Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy
预先存在的虚弱对接受辅助治疗的乳腺癌患者心脏毒性的影响
- DOI:
10.1016/j.jaccao.2024.10.012 - 发表时间:
2025-02-01 - 期刊:
- 影响因子:12.800
- 作者:
Shuang Yang;Xiwei Lou;Mustafa M. Ahmed;Stephen E. Kimmel;Karen C. Daily;Thomas J. George;Carl J. Pepine;Jiang Bian;Dejana Braithwaite;Dongyu Zhang;Yi Guo - 通讯作者:
Yi Guo
Thomas J. George的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas J. George', 18)}}的其他基金
相似海外基金
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
- 批准号:
EP/Z531480/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
- 批准号:
EP/Z531509/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
- 批准号:
EP/Z53156X/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
- 批准号:
EP/Z531625/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
- 批准号:
EP/Z531728/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
- 批准号:
EP/Z531844/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Natural History Museum
2024 年开放访问区块奖 - 自然历史博物馆
- 批准号:
EP/Z531856/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Brighton
2024 年开放获取区块奖 - 布莱顿大学
- 批准号:
EP/Z531935/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Bristol
2024 年开放获取区块奖 - 布里斯托大学
- 批准号:
EP/Z531947/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Bradford
2024 年开放获取区块奖 - 布拉德福德大学
- 批准号:
EP/Z531923/1 - 财政年份:2024
- 资助金额:
$ 11.53万 - 项目类别:
Research Grant